Glenmark Pharmaceuticals (GLENMARK.NSE) Q2 2025 Earnings

23MayConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
10.05
11.64
13.23
14.82

Details

Expected EPS
12.04076014482
Actual EPS
10.050551856419998
Surprise EPS
-1.99
Surprise Percent
+16.53%

Description

Glenmark Pharmaceuticals (GLENMARK.NSE) has reported earnings of 10.050551856419998 per share for Q2 2025.

0 Comments

Share your thoughts